Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death‐ligand 1 by sponging microRNA‐195‐5p
Wenyang Zhou, Mingming Zhang, Chang Liu, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 12, pp. 23176-23189
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi, Jung-Mao Hsu, Wenhao Yang, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 5, pp. 287-305
Closed Access | Times Cited: 331
Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)
Weijun Hong, Min Xue, Jun Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 288
Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives
Jin‐Yu Sun, Dengke Zhang, Songquan Wu, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 182
The role of cancer-derived microRNAs in cancer immune escape
Ming Yi, Linping Xu, Ying Jiao, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 177
LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis
Hao Zhang, Changhao Zhu, Zhiwei He, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 144
The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang, Shuya Pan, Xin Chen, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 120
Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review
Tohada M. AL‐Noshokaty, Abdallah Mansour, Rehab Abdelhamid, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154438-154438
Closed Access | Times Cited: 52
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Long noncoding RNA: a dazzling dancer in tumor immune microenvironment
Yalu Zhang, Qiaofei Liu, Quan Liao
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 91
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
Alexandre Perrier, Audrey Didelot, Pierre Laurent‐Puig, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1061-1061
Open Access | Times Cited: 73
Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
Ya Luo, Jiqiao Yang, Jing Yu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 72
Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology
Noha Mousaad Elemam, Radwa Y. Mekky, Gowhar Rashid, et al.
Expert Reviews in Molecular Medicine (2024) Vol. 26
Open Access | Times Cited: 8
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy
Lokesh Kadian, Deepika Verma, Neelam Lohani, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3229-3254
Closed Access | Times Cited: 8
Long non-coding RNAs: Emerging regulators of invasion and metastasis in pancreatic cancer
Mengmeng Shi, Rui Zhang, Hui Lyu, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Noncoding RNAs as potential mediators of resistance to cancer immunotherapy
Radhakrishnan Vishnubalaji, Hibah Shaath, Ramesh Elango, et al.
Seminars in Cancer Biology (2019) Vol. 65, pp. 65-79
Closed Access | Times Cited: 73
PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Life Sciences (2020) Vol. 256, pp. 117899-117899
Closed Access | Times Cited: 65
The Role of Long Non-coding RNAs in Immunotherapy Resistance
Yuwen Zhou, Yajuan Zhu, Yao Xie, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 55
Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential
Ya-Nan Pi, Wen-Cai Qi, Bairong Xia, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52
Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance
Rana Shafabakhsh, Farzaneh Arianfar, Massoud Vosough, et al.
Cancer Gene Therapy (2021) Vol. 28, Iss. 12, pp. 1229-1255
Open Access | Times Cited: 47
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 19
Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm
Jing Zhang, Le Wu, Chenchen Wang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1385-1398
Open Access | Times Cited: 7
Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy
Elena Shklovskaya, Helen Rizos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7139-7139
Open Access | Times Cited: 48
Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression
Najwa Skafi, Mohammad Fayyad‐Kazan, Bassam Badran
Gene (2020) Vol. 754, pp. 144888-144888
Closed Access | Times Cited: 41
Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1
Wei Liu, Han Chen, Dongsheng Wang
Immunopharmacology and Immunotoxicology (2021) Vol. 43, Iss. 4, pp. 443-451
Closed Access | Times Cited: 39
Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy
Giasemi C. Eptaminitaki, Nora Wolff, Dimitris Stellas, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3313-3313
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top